Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.

NCT01720069 is registered in ClinicalTrials.gov with Vectura Limited as lead sponsor.

NCT NCT01720069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01720069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.
Lead sponsor
Vectura Limited
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2012
Completion date
October 31, 2013
Enrollment
197 (actual)
Sites
77

Conditions

As the registry lists them; a condition with its own page is linked.

asthma